ArticleFrontiers in pharmacology2026

Harnessing human immune system models to validate NADPH oxidase 1 inhibition as treatment for hepatocellular carcinoma.

Zenzi De Vos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.